NOMENKLATURA E KOMBINUAR E MALLRAVE 2010

Kodi NK CAS RN Emri4132-28-9 2,3,4,6-tetra-O-benzyl-D-glucose6564-72-3 2,3,4,6-tetra-O-benzyl-D-glucopyranose13035-61-5 1,2,3,5-tetraacetyl-beta-D-ribofuranose24259-59-4 L-ribose80312-55-6 2,3,4,6-tetra-O-benzyl-1-O-(trimethylsilyl)-beta-D-glucose182410-00-0 beta-cyclodextrin sulfobutyl ethers, sodium salts270071-40-4 benzyl 2,6-dimethoxy-4-{(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)oxy]-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl}phenylcarbonate471863-88-4 2,3-di-O-benzyl-4,6-O-((1R)-ethylidene)-D-xylo-hexopyranose473799-30-3 (5S,5aS,9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside2941 90 00 13292-22-3 3-formylrifamycin14487-05-9 rifamycin O19130-96-2 (2S,3S,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol54122-50-8 dicyclohexylammmonium (7R)-3-(acetoxymethyl)-7-[2-({(3R)-3-[(tert-butoxycarbonyl)amino]-3-carboxypropyl}amino)-2-oxoethyl]-3,4-didehydrocepham-4-carboxylate or cephalosporin Ddicyclohexylamine salt3002 10 95 42617-41-4 Blood-coagulation factor XIVa116638-33-6 SC-597353003 90 141256-04-4 1-(28-{O-D-apio-beta-D-furanosyl-(1,3)-O-beta-D-xylopyranosyl-(1,4)-O-6-deoxy-alpha-L-mannopyranosyl)-(1,2)-4-O-[5-(5-alpha-L-arabinofuranosyloxy-3-hydroxy-6-methyloctanoyloxy)-3-hydroxy-6-methyloctanoyl]-6-deoxy-beta-D-galactopyranosyloxy}-16-alphahydroxy-23-beta,28-dioxoolean-12-en-3-beta-yl)-O-beta-Dgalactopyranosyl-(1,2)-O-beta-D-xylopyranosyl-(1,3)-beta-Dglucopyranosiduronicacid3006 30 00 155773-56-1 ferristene195993-11-4 hemocyanins, megathura crenulata, reaction products with 1 -O-[O-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1,4)-O-(N-acetylalpha-neuraminosyl)-(2,3)-O-beta-D-galactopyranosyl-(1,4)-beta-Dglucopyranose3507 90 90 0-00-0 fibrinuclease, powder9001-63-2 lysozyme12/4/9002 urate oxidase9003-98-9 deoxyribonuclease3824 90 0-00-0 4-(2-aminoethylthiomethyl)-1,3-thiazol-2-ylmethyl(dimethyl)amine,in the form of a solution in toluene0-00-0 alpha-(6-fluoro-2-methylinden-3-yl)-p-tolyl methyl sulfide, in theform of a solution in toluene3824 90 64 0-00-0 Intermediate concentrate obtained from a genetically -modified E. colifermentation medium, containing human granulocyte -macrophagecolony-stimulating factor; for use in the manufacture of medicamentsof HS heading 3002